SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-020869
Filing Date
2022-08-04
Accepted
2022-08-04 07:52:03
Documents
14
Period of Report
2022-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lnth-20220804.htm   iXBRL 8-K 36479
2 EX-99.1 exhibit991q22022earningspr.htm EX-99.1 255331
6 newlantheuslogo.jpg GRAPHIC 3408
  Complete submission text file 0001628280-22-020869.txt   450713

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20220804.xsd EX-101.SCH 1908
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20220804_lab.xml EX-101.LAB 23924
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20220804_pre.xml EX-101.PRE 12600
8 EXTRACTED XBRL INSTANCE DOCUMENT lnth-20220804_htm.xml XML 11024
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 221134755
SIC: 2835 In Vitro & In Vivo Diagnostic Substances